Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review

Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review

Neoadjuvant chemotherapy (NAC) is often used to treat locally advanced disease for tumor downstaging, thus improving the chances of breast-conserving surgery. From the NAC response, it is possible to obtain prognostic information as patients may reach a pathological complete response (pCR). Those wh...

Full description

Bibliographic Details
Main Authors: Ana Julia Aguiar de Freitas, Rhafaela Lima Causin, Muriele Bertagna Varuzza, Cassio Murilo Trovo Hidalgo Filho, Vinicius Duval da Silva, Cristiano de Pádua Souza, Márcia Maria Chiquitelli Marques
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Cancers
Subjects:
pathological complete response
neoadjuvant chemotherapy
breast cancer
molecular biomarkers
Online Access:https://www.mdpi.com/2072-6694/13/21/5477

Internet

https://www.mdpi.com/2072-6694/13/21/5477

Similar Items